XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Common Stock, Stock Options and Warrants (Details) - USD ($)
 1 Months Ended 6 Months Ended
Nov. 02, 2021
Nov. 01, 2021
Oct. 11, 2021
Oct. 06, 2020
Mar. 21, 2022
Feb. 28, 2022
Jan. 31, 2022
May 24, 2021
Feb. 19, 2021
Feb. 16, 2021
Jan. 27, 2021
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Sep. 30, 2021
Jun. 21, 2021
Dec. 31, 2020
Nov. 05, 2020
Sep. 30, 2020
Sep. 11, 2020
Feb. 10, 2020
Feb. 07, 2018
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Common shares authorized                       400,000,000     400,000,000              
Common stock offerings, description                     the Company closed a private placement for 15,455,960 common shares and warrants to purchase 7,727,980 common shares, at a purchase price of $1.294 per common share and accompanying warrant, for gross proceeds of $20,000,012. The 7,727,980 warrants are immediately exercisable at $1.231 per common share for a term of five and one-half years. The Company paid the placement agent a fee of 7% of the gross proceeds totaling $1,400,001 and issued the placement agent 1,081,917 immediately exercisable warrants at $1.6175 per common share for a term of five and one-half years. The Company also reimbursed the placement agent for $85,000 in expenses and incurred $64,601 in other expenses. Net proceeds from the offering were $18,450,410. The estimated fair value of the 7,727,980 warrants issued to the investors was approximately $7,582,000 and the estimated fair value of the 1,081,917 warrants issued to the placement agent was approximately $1,025,000.                      
Issued shares         100,000                                  
Fair value of common stock (in Dollars)         $ 178,000                                  
Common shares reserved                                   2,000,000        
Option to purchase share outstanding                       4,775,000                    
Remaining shares                                       7,500,000    
Shares available for future grants                       3,965,000                    
Issued shares of purchase   200,000 175,000 125,000   300,000 300,000                              
Share price (in Dollars per share)   $ 1.87 $ 2.04 $ 1.01               $ 1.69                    
Options vest over terms                       10 years 10 years                  
Share issued price per share                         0.93                  
Stock-based compensation expense description                       Stock-based compensation expense for the three months ended March 31, 2022 and 2021 was $1,020,998 (including $33,333 for the NoveCite Stock Plan) and $342,962 (including $18,833 for the NoveCite Stock Plan), respectively. Stock-based compensation expense for the six months ended March 31, 2022 and 2021 was $1,925,602 (including $66,666 for the NoveCite Stock Plan) and $619,544 (including $31,389 for the NoveCite Stock Plan), respectively.                     
Citius stock plans (in Dollars)                       $ 7,151,673                    
Weighted average period term                       2 years 3 months 18 days                    
Common shares outstanding                       2,000,000                    
Stock option plan , description                       NoveCite has options outstanding to purchase 2,000,000 common shares at a weighted average exercise price of $0.24 per share, of which 376,665 are exercisable. All of these options vest over 36 months and have a term of 10 years. The weighted average remaining contractual term of options outstanding under the NoveCite Stock Plan is 8.9 years. At March 31, 2022, unrecognized total compensation cost related to unvested awards under the NoveCite Stock Plan of $249,778 is expected to be recognized over a weighted average period of 1.9 years.                    
Common Stock [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Issued shares 50,201                                          
Fair value of common stock (in Dollars) $ 95,884                                          
Shares outstanding                       146,129,630 134,701,219 146,029,630 145,979,429   55,576,996   55,576,996      
Issued shares of purchase     375,000 175,000                                    
Warrants [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Weighted average remaining life of the outstanding warrants                       3 years 3 months 18 days                    
Aggregate intrinsic value for the warrants outstanding (in Dollars)                       $ 11,206,022                    
Minimum [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Shares of capital stock authorized                               210,000,000            
Common shares authorized                               200,000,000            
Exercise price (in Dollars per share)           $ 1.44 $ 1.44                              
Maximum [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Shares of capital stock authorized                               410,000,000            
Common shares authorized                               400,000,000            
Exercise price (in Dollars per share)           $ 1.49 $ 1.49                              
Board of Directors [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Issued shares of purchase     2,515,000 800,000                                    
Board of Directors Chairman [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Issued shares of purchase                   125,000                        
Share price (in Dollars per share)                   $ 1.69                        
Registered Direct Offering [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Common stock offerings, description                 the Company closed a registered direct offering for 50,830,566 common shares and warrants to purchase up to 25,415,283 common shares, at a purchase price of $1.505 per share of common stock and accompanying warrant, for gross proceeds of $76,500,002. The 25,415,283 warrants are immediately exercisable at $1.70 per common share for a term of five years. The Company paid the placement agent a fee of 7% of the gross proceeds totaling $5,355,000 and issued the placement agent 3,558,140 immediately exercisable warrants at $1.881 per common share for a term of five years. The Company also reimbursed the placement agent for $85,000 in expenses and incurred $80,160 in other expenses. Net proceeds from the offering were $70,979,842. The estimated fair value of the 25,415,283 warrants issued to the investors was approximately $42,322,000 and the estimated fair value of the 3,558,140 warrants issued to the placement agent was approximately $5,850,000.                          
2014 Stock Incentive Plan [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Common stock for issuance                       866,667                    
Shares outstanding                       855,171                    
2018 Omnibus Stock Incentive Plan [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Common stock for issuance                                           2,000,000
Number of shares outstanding                       1,820,000                    
2020 Stock Plan [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Common shares reserved                                         3,110,000  
2021 Omnibus Stock Incentive Plan [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Option to purchase share outstanding                       1,870,000                    
Remaining shares                       1,240,000                    
2021 Stock Plan [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Issued shares               8,740,000                            
Shares available for future grants                       3,965,000                    
Stock Options [Member]                                            
Common Stock, Stock Options and Warrants (Details) [Line Items]                                            
Contractual term                       10 years